10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001638833-22-000096`
Period End Date	20220331
Filing Date	20220503
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	sgry-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 59 Cash Flow Statement 66 Stockholders Equity 24 Comprehensive Income 10

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$294.60M	USD	Point-in-time
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$272.30M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$389.90M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$378.90M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$412.40M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$430.20M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$61.10M	USD	Point-in-time
Inventories	`InventoryNet`	$62.90M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$25.60M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$32.20M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$50.60M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$39.30M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	89.33M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$937.00M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	89.90M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$946.10M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $294.6 and $272.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$778.90M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	89.90M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $294.6 and $272.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$629.70M	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.96B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.97B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$88.70M	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$94.50M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$277.40M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$324.10M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$114.40M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$113.90M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$59.10M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$120.00M	USD	Point-in-time
Total assets	`Assets`	$6.12B	USD	Point-in-time
Total assets	`Assets`	$6.29B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$122.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$124.90M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$83.80M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$77.10M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$64.40M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$46.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$210.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$221.10M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$60.40M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$68.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$536.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$542.30M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$3.03B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.88B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$272.10M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$315.60M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$87.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$95.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$306.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$330.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$341.50M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$308.20M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,904,913 and 89,332,557, respectively	`CommonStockValueOutstanding`	$900.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,904,913 and 89,332,557, respectively	`CommonStockValueOutstanding`	$900.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.62B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.63B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$25.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-31.50M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-490.50M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-502.70M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$1.09B	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$1.16B	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$880.60M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$851.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.29B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.12B	USD	Point-in-time

Income Statement 59 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$512.40M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$596.20M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$151.70M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$178.90M	USD	1 Quarter
Supplies	`SuppliesExpense`	$147.30M	USD	1 Quarter
Supplies	`SuppliesExpense`	$171.60M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$63.60M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$55.50M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$22.80M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$20.00M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$31.60M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$37.30M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$408.90M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$471.40M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$26.80M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$29.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$27.40M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$5.30M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$7.10M	USD	1 Quarter
Grant funds	`GrantRevenue`	$15.10M	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.20M	USD	1 Quarter
Gain on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$100.00K	USD	1 Quarter
Gain on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$900.00K	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$2.60M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$3.10M	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	Point-in-time
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	-	USD	1 Quarter
Other income, net	`OtherNonrecurringIncomeExpense`	$-2.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$495.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$448.10M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$100.40M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$64.30M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-53.30M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-56.30M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$11.00M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$44.10M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$200.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.30M	USD	1 Quarter
Net income	`ProfitLoss`	$10.80M	USD	1 Quarter
Net income	`ProfitLoss`	$42.80M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$31.80M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Net income (loss) attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Net income (loss) attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-21.00M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	-	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.30M	USD	1 Quarter
Net income (loss) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-31.30M	USD	1 Quarter
Net income (loss) attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$12.20M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$0.14	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$0.14	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.77M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.00M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.77M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.27M	shares	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$10.80M	USD	1 Quarter
Net income	`ProfitLoss`	$42.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$27.40M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-1.60M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-6.10M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$3.70M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$5.20M	USD	1 Quarter
Gain on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$100.00K	USD	1 Quarter
Gain on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$900.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-100.00K	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$200.00K	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$900.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$8.60M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$9.80M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.90M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.00M	USD	1 Quarter
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-18.00M	USD	1 Quarter
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-7.20M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-1.60M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-7.20M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$79.80M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$50.20M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.50M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.20M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.10M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$31.10M	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	-	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$2.30M	USD	1 Quarter
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	1 Quarter
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$11.50M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$9.30M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.10M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-14.30M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$16.60M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$17.00M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$600.00K	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$11.90M	USD	1 Quarter
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.10M	USD	1 Quarter
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	$260.90M	USD	1 Quarter
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	$12.60M	USD	1 Quarter
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	1 Quarter
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	1 Quarter
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$5.10M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$31.30M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$36.20M	USD	1 Quarter
(Payments) receipts related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$3.10M	USD	1 Quarter
(Payments) receipts related to ownership transactions with non-controlling interest holders	`ProceedsFromMinorityShareholders`	$1.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-8.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$700.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-43.70M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$187.80M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.00M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$223.70M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$378.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$541.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$378.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$541.90M	USD	Point-in-time

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	89.90M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$32.20M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$100.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.70M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.30M	USD	1 Quarter
Equity offering	`StockIssuedDuringPeriodValueNewIssues`	$248.30M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$56.80M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$2.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-29.10M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$24.60M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.80M	USD	1 Quarter
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	89.90M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	89.33M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$10.80M	USD	1 Quarter
Net income	`ProfitLoss`	$42.80M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$56.80M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$17.20M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$99.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$31.80M	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$69.00M	USD	1 Quarter
Comprehensive income (loss) attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-14.60M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.